The science of α2M
Structure, the trapping mechanism, protease and cytokine inhibition, gene regulation, and the primary literature.
OpenProcessing protocols
Stall-side processing for the Alpha2EQ®-30 and Alpha2EQ®-15 kits, plus the nebulizing protocol for airway inflammation.
OpenResearch library
Peer-reviewed papers, technical bulletins, white papers and the QuickStart and best-practices guides.
OpenClinical team
Protocol training, dosing guidance, kit logistics and the full reference list on request.
OpenWhere it is used
Alpha2EQ® has no contraindications for use before or after PRP, IRAP, stem cells, amnion-based products or shockwave therapy, and can be used in horses actively competing under regulated rules and in horses where corticosteroids should be avoided.
Joints
Osteoarthritis and post-traumatic osteoarthritis: coffin, fetlock, carpal, hock, stifle, SI and cervical facet joints among others.
Soft tissues
Tendon and ligament inflammation including suspensory branch, deep digital flexor tendon and collateral ligament lesions; bursitis including navicular bursa.
Airways
Nebulized α2M for airway inflammation, with a pilot study in equine asthma.